You are here

  • Home
  • Archive
  • Volume 9, Issue 1
  • Bortezomib in antibody-mediated autoimmune diseases (TAVAB): study protocol for a unicentric, non-randomised, non-placebo controlled trial

Article metrics

Article menu

Download PDFPDF

Rheumatology
Protocol
Bortezomib in antibody-mediated autoimmune diseases (TAVAB): study protocol for a unicentric, non-randomised, non-placebo controlled trial

 

Online download statistics by month:

Online download statistics by month: January 2019 to April 2021

AbstractFullPdf
Jan 201931931625
Feb 201956655389
Mar 20191029524
Apr 201911010622
May 2019958939
Jun 2019625920
Jul 2019383517
Aug 2019494412
Sep 2019424111
Oct 201911711343
Nov 2019585320
Dec 2019565614
Jan 2020565310
Feb 2020635917
Mar 2020494615
Apr 2020262519
May 2020373441
Jun 2020252413
Jul 2020312916
Aug 2020383019
Sep 2020242014
Oct 20201049537
Nov 2020353213
Dec 202019168
Jan 2021282712
Feb 2021434112
Mar 2021403713
Apr 2021312910
Total22632157605